Taipei, Taiwan

Shu-Jen Chen

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 53(Granted Patents)


Location History:

  • Keelung, TW (2004)
  • Buffalo, NY (US) (2009)
  • Taipei, TW (2004 - 2022)

Company Filing History:


Years Active: 2004-2022

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Innovations and Contributions of Inventor Shu-Jen Chen

Introduction: Shu-Jen Chen is a notable inventor based in Taipei, Taiwan, recognized for her significant contributions to the field of biomedical innovations. With an impressive portfolio of 12 patents, her work primarily focuses on addressing critical healthcare challenges, particularly in cancer treatment and antibiotic resistance.

Latest Patents: Among her latest inventions is a patent for a ranking system for immunogenic cancer-specific epitopes. This innovative system outlines methods to identify, predict, and rank T-cell epitopes linked to disease-associated mutations. These epitopes are crucial for eliciting immune responses from T cells and are tailored for personalized cancer treatments. Another noteworthy patent involves the treatment of infections caused by antibiotic-resistant bacteria. This method provides a novel approach to combat infections from various resistant strains by administering effective compounds, thereby offering new hope in the fight against antibiotic resistance.

Career Highlights: Shu-Jen Chen has had a distinguished career, working with reputable organizations such as Taigen Biotechnology Company, Ltd. and the National Health Research Institutes. Her expertise and dedication in the biomedical field have established her as a leader in her area of research and innovation.

Collaborations: Throughout her career, she has collaborated with esteemed colleagues like Chu-Chung Lin and Ming-Chu Hsu, contributing to the advancement of research and innovation in biomedical applications. These collaborations have helped enhance the impact and reach of her inventions, paving the way for further advancements in the medical industry.

Conclusion: Shu-Jen Chen’s innovative work and multiple patents underline her dedication to improving healthcare solutions. Her research on cancer-specific epitopes and resistant bacterial infections demonstrates her commitment to addressing some of the most pressing challenges in medicine today. As she continues her efforts, her contributions will undoubtedly have a lasting impact on the fields of immunology and infectious disease treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…